2,3,4-Trimethoxybenzaldehyde | CAS:2103-57-3

We serve 2,3,4-Trimethoxybenzaldehyde CAS:2103-57-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,3,4-Trimethoxybenzaldehyde

Chemical Name: 2,3,4-Trimethoxybenzaldehyde
CAS.NO: 2103-57-3
Synonyms: 
2,3,4-Trimethoxybenzaldehyde
Benzaldehyde,2,3,4-trimethoxy
2-hydroxy-3-4-dimethoxybenzaldehyde
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 312.0±37.0 °C at 760 mmHg
Melting Point 38-40 °C(lit.)
Molecular Formula C10H12O4
Molecular Weight 196.200
Flash Point 137.1±26.5 °C
 
Specification:
Appearance: white to pale yellow crystalline powder
Assay: ≥99.0% (GC)
Melting point: 38-41 ° C (2 ° C)
Moisture: ≤0.5%
Single impurity: ≤0.5%
Total impurities: ≤0.5%
Ethanol dissolution test: qualified
 
Packing specification: 25kg/cardboard drum, lined with double plastic bag
Production capacity: 100 tons / year
Application: pharmaceutical intermediates



Contact us for information like 2,3,4-Trimethoxybenzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-hydroxy-3-4-dimethoxybenzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-hydroxy-3-4-dimethoxybenzaldehyde Use and application,2-hydroxy-3-4-dimethoxybenzaldehyde technical grade,usp/ep/jp grade.


Related News: The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.LINOLEIC ACID SODIUM SALT manufacturer TSA notified airlines Saturday about the restrictions. CNN is reaching out to TSA for comment.2,5-Diamino-4,6-dihydroxypyrimidine hydrochloride supplier ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.2-(4-CHLOROPHENOXY)ANILINE vendor Who is at risk of infection? People of all ages can be infected with the virus, but older people and those with pre-existing medical conditions are especially vulnerable to severe complications.A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.